Last update :
28/04/2024
Glucose-lowering   Insulin glulisine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Apidra Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Shorant Mexico
References   Injection   References : Insulin glulisine  
Type Publication
3935 Manufacturer Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit
Sanofi Laboratoire 2016
4433 Journal Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Clin Ther 2020 ; 42, 3: 475-485.

  Mentions Légales